Drug Type Small molecule drug |
Synonyms |
Action antagonists |
Mechanism Angiotensin II receptor antagonists, Purinergic P2 receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 1 | Canada | - | |
| Metabolic Syndrome | Phase 1 | Canada | - |





